WaferGen Biosystems Competitors and Similar CompaniesClear all

WaferGen Biosystems's competitors and similar companies include Sphere Fluidics, Biotools B&M Labs, PrimeCell Advanced Therapy and Biotage.
WaferGen Biosystems
WaferGen Biosystems
WaferGen Biosystems is a biotechnology company that provides innovative genomic technology solutions for single-cell analysis and clinical research.
Sphere Fluidics
Sphere Fluidics
Sphere Fluidics develops novel single cell analysis systems for research, therapeutic, bioproduction and diagnostic applications.
Biotools B&M Labs
Biotools B&M Labs
Biotools B&M Labs is a company developing a range of solutions in the biomedicine, biotechnology and life sciences sectors.
PrimeCell Advanced Therapy
PrimeCell Advanced Therapy
PrimeCell Advanced Therapy is a company that focuses on discovering biological drugs to support the regeneration of human tissues and organs.
Biotage
Biotage
Biotage is a life science company that provides solutions, knowledge, and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation, and purification.
Founding Date
Founding Date
2003
Founding Date
2010
Founding Date
1996
Founding Date
2007
Founding Date
1997
Type
Type
Subsidiary
Type
Private
Type
Private
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Fremont, US HQ
Luxembourg, LU
Locations
Cambridge, GB HQ
South Brunswick Township, US
Locations
Madrid, ES HQ
Locations
Prague, CZ HQ
Ostrava, CZ
Bratislava, SK
Locations
Uppsala, SE HQ
New Delhi, IN
Koto City, JP
Seongnam Si, KR
Singapore, SG
Lund, SE
see more
Employees
Employees
28
Employees
1041% decrease
Employees
13
Employees
17
Employees
622

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
Kč23.5m (FY, 2018)
Revenue (est.)
kr2.1b (FY, 2024)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
Kč14.8m (FY, 2018)
Cost of goods
kr754m (FY, 2024)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
Kč8.7m (FY, 2018)
Gross profit
kr1.4b (FY, 2024)
Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
Kč12.4m (FY, 2018)
Net income
kr284m (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 56.9m
Total funding raised
$ 19.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Sphere Fluidics
HQ
Cambridge, GB
Employees
104↓ 1% decrease

Sphere Fluidics develops novel single cell analysis systems for research, therapeutic, bioproduction and diagnostic applications.

View company
Biotools B&M Labs
HQ
Madrid, ES
Employees
13

Biotools B&M Labs is a company developing a range of solutions in the biomedicine, biotechnology and life sciences sectors.

View company
PrimeCell Advanced Therapy
HQ
Prague, CZ

PrimeCell Advanced Therapy is a company that focuses on discovering biological drugs to support the regeneration of human tissues and organs.

View company
Biotage
HQ
Uppsala, SE
Employees
622

Biotage is a life science company that provides solutions, knowledge, and experience in the areas of analytical chemistry, medicinal chemistry, peptide synthesis, separation, and purification.

View company